InventisBio
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (28)
A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer
Started: 9/15/2022
A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis
Started: 1/12/2026
Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis
Started: 9/18/2025
A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
Started: 2/12/2026
A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis
Started: 1/16/2026
A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis
Started: 5/22/2025
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Started: 5/1/2026
Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis
Started: 1/31/2024
Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout
Started: 4/17/2023
Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients
Started: 9/28/2022
D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer
Started: 2/28/2019
Single and Multiple Dose and Food Effect Study to Evaluate the Safety, Tolerability and Pharmacokinetics of D-2570 Tablets in Healthy Subjects
Started: 8/13/2024
Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors
Started: 10/12/2022
Study to Evaluate D-1553 in Subjects With Solid Tumors
Started: 10/2/2020
Study to Evaluate D-1553 in Subjects With Lung Cancer
Started: 3/16/2021
A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer
Started: 9/13/2022
A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553
Started: 5/24/2023
Mass Balance Study of [14C] D-1553 in Chinese Healthy Adult Male Subjects
Started: 12/8/2023
A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer
Started: 3/18/2018
Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female Subjects
Started: 10/27/2021
Phase I Study of D-0120 to Evaluate Safety and PK/PD Study in Healthy Volunteers
Started: 9/18/2019
Food Effect Study of D-0502 Tablet in Healthy Volunteers
Started: 10/23/2018
D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers
Started: 9/13/2017